Cleared Traditional

K802647 - ECA GEL PROUDUCT REFORMULATION

K802647 is an FDA 510(k) clearance for ECA GEL PROUDUCT REFORMULATION, manufactured by Vanaray Laboratories, Inc.. The device is a Class 2 Neurology device with product code GYB cleared through the Traditional 510(k) pathway after a 80-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1981
Decision
80d
Days
Class 2
Risk

K802647 is an FDA 510(k) clearance for the ECA GEL PROUDUCT REFORMULATION. Classified as Media, Electroconductive (product code GYB), Class II - Special Controls.

Submitted by Vanaray Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on January 8, 1981 after a review of 80 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1275 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K802647

510(k) Number K802647 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 20, 1980
Decision Date January 08, 1981
Days to Decision 80 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 149d · This submission: 80d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GYB Device Classification - Class 2, Special Controls

Product Code GYB Media, Electroconductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1275
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GYB Media, Electroconductive

All 68
Devices cleared under the same product code (GYB) and FDA review panel - the closest regulatory comparables to K802647.
KENZ-GELECT GEL PAD
K820991 · Suzuken Co., Ltd. · Apr 1982
KENZ-GELECT
K812263 · Suzuken Co., Ltd. · Nov 1981
ZEE ELECTRODE-GEL
K812284 · Zee Medical Products Co., Inc. · Sep 1981
RODEL ELECTRODERM PADS
K802658 · Rodel Products Corp. · Dec 1980
ECG & ULTRASOUND GELS, CREAMS & LOTION
K803151 · Abco Dealers, Inc. · Dec 1980
UCA CREAM PRODUCT REFORMULATION
K802648 · Vanaray Laboratories, Inc. · Nov 1980